Sep 19, 2017 ProMIS Neurosciences could have a groundbreaking Alzheimer’s treatment, Mackie Research says
Sep 13, 2017 Reuters: BRIEF-ProMIS Neurosciences designates PMN330 as 3rd, validated lead product for development in alzheimer’s disease